Neutral Results Obtained in the ELIXA Trial. Issue 28 (29th October 2015)

• Record Type: Journal Article
• Authors: Cunningham, Muriel
• Other Names: Lewis Eldrin F. presenter.
• Is Part Of: MD conference express. Volume 15:Issue 28(2015)
• Page Start: 14
• Page End: 14
• Publication Date: 2015-10-29
• Subjects: acute coronary syndrome -- clinical trial -- diabetes mellitus -- ELIXA -- heart failure -- lixisenatide -- randomized trial; Medicine -- Congresses; 610
• DOI: 10.1177/1559897715611120
• Languages: English
• ISSNs: 1559-8977

Abstract

ELIXA was a randomized, double-blind, placebo-controlled trial among patients with type 2 diabetes mellitus who had experienced a recent acute coronary syndrome event. Lixisenatide was not superior to placebo in the primary composite end point of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization for unstable angina.